Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Immunogenicity of Cervarix™ in Human Immunodeficiency Virus Infected Females

NCT01031069 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01031069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01031069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Immunogenicity of Cervarix™ in Human Immunodeficiency Virus Infected Females
Lead sponsor
GlaxoSmithKline
Phase
Phase 4
Overall status
Completed
Start date
October 26, 2010
Completion date
April 19, 2017
Enrollment
873 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

infections, papillomavirus, papillomavirus vaccines